Heart Failure

This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congesitive heart failure (CHF). The channel includes news on HFpEF and HFrEF.

Diabetes Drug Effective Against Heart Failure in Wide Spectrum of Patients
News | Heart Failure | March 29, 2019

March 29, 2019 — The cardiovascular benefits of the diabetes...

New data from a four-week extension of the landmark PIONEER-HF Trial showed the drug sacubitril/valsartan (Entresto) continued to deliver reductions in the heart failure biomarker N-terminal pro–B-type natriuretic peptide (NT-proBNP), an established biomarker for heart failure severity and prognosis.[1] The data was presented as a late-breaker at the American College of Cardiology (ACC) 2019 Annual Scientific Session in March.
News | Heart Failure | March 27, 2019

March 27, 2019 —New data from a four-week extension of the landmark PIONEER-HF Trial showed the drug sacubitril/...

Toilet Seat Detects Congestive Heart Failure

Nicholas Conn, a postdoctoral fellow at RIT and founder and CEO of Heart Health Intelligence, is part of the university team that has developed a toilet-seat based cardiovascular monitoring system. Image courtesy of A. Sue Weisler/RIT.

News | Heart Failure | March 26, 2019

March 26, 2019 — A toilet seat-based...

HeartMate 3 Pump Shows Superior Outcomes in Advanced Heart Failure
News | Ventricular Assist Devices (VAD) | March 22, 2019

March 22, 2019 — Severely ill patients with advanced...

FDA Approves Optimizer Smart System for Heart Failure Patients offers cardiac contractility modulation.
Technology | Heart Failure | March 21, 2019

March 21, 2019 — The U.S. Food and Drug Administration (FDA) approved Impulse Dynamics’ Optimizer Smart system for...

The opening late-breaking trial at ACC 2019 is the Apple Heart Study, a large-scale, app-based study to identify atrial fibrillation using a smartwatch. Earlier, smaller trials showed this approach might be used in a population health application to proactively identify AFib patients earlier.

Feature | ACC | March 19, 2019

The American College of Cardiology (ACC) released a list of the...

FDA Approves 3T Acticor and Rivacor Tachycardia Devices from Biotronik
Technology | Cardiac Resynchronization Therapy Devices (CRT) | March 15, 2019

March 15, 2019 – Biotronik announced U.S. Food and Drug Administration (FDA) approval of the Acticor and Rivacor...

FDA Approves MitraClip for Use in Heart Failure Patients With Functional Mitral Regurgitation
Feature | Heart Valve Technology | March 14, 2019 | Jeff Zagoudis, Associate Editor

March 14, 2019 — The U.S. Food and Drug Administration (FDA) approved the MitraClip...

William T. Abraham, M.D., Joins V-Wave as Chief Medical Officer

William T. Abraham, M.D., in an interview with DAIC Editor Dave Fornell at TCT 2016.

News | Heart Failure | March 12, 2019

March 12, 2019 — V-Wave Ltd. announced that renowned heart failure cardiologist...

FDA Releases Final Guidances on Regenerative Medicine Therapies
News | Stem Cell Therapies | March 04, 2019

March 4, 2019 — The U.S. Food and Drug Administration (FDA) recently finalized two guidance documents regarding...

AT&T Demonstrates Connectivity With Smart Scale at HIMSS 2019
News | Remote Monitoring | February 21, 2019

February 21, 2019 — At the recent Healthcare...

Overlay Init